Cargando…

Prescription of oral short-acting beta 2-agonist for asthma in non-resource poor settings: A national study in Malaysia

OBJECTIVE: Use of oral short-acting beta 2-agonist (SABA) persists in non-resource poor countries despite concerns for its lower efficacy and safety. Utilisation and reasons for such use is needed to support the effort to discourage the use of oral SABA in asthma. This study examined the frequency o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chin, May Chien, Sivasampu, Sheamini, Khoo, Ee Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5491245/ https://www.ncbi.nlm.nih.gov/pubmed/28662193 http://dx.doi.org/10.1371/journal.pone.0180443

Ejemplares similares

Health profiles of foreigners attending primary care clinics in Malaysia
por: Ab Rahman, Norazida, et al.
Publicado: (2016)

Chasm in primary care provision in a universal health system: Findings from a nationally representative survey of health facilities in Malaysia
por: Lim, Huy Ming, et al.
Publicado: (2017)

Short-acting β(2)-agonist prescriptions are associated with poor clinical outcomes of asthma: the multi-country, cross-sectional SABINA III study
por: Bateman, Eric D., et al.
Publicado: (2022)

Evaluation of short-acting Beta-2-agonist prescriptions and associated clinical outcomes: Findings from the SABA use IN Asthma (SABINA) study in Asia
por: Wang, Hao-Chien, et al.
Publicado: (2023)

Antibiotic prescribing in public and private practice: a cross-sectional study in primary care clinics in Malaysia
por: Ab Rahman, Norazida, et al.
Publicado: (2016)

Short-acting beta-2 agonist prescription patterns and clinical outcomes in Chinese patients with asthma: an observational study in mainland China for the SABINA programme
por: Bao, Wuping, et al.
Publicado: (2022)

Paradoxical Bronchoconstriction with Short-Acting Beta Agonist
por: Magee, Jared S., et al.
Publicado: (2018)

Variation of polypharmacy in older primary care attenders occurs at prescriber level
por: Ong, Su Miin, et al.
Publicado: (2018)

Short-acting β(2)-agonist prescription patterns in patients with asthma in Turkey: results from SABINA III
por: Yorgancıoğlu, Arzu, et al.
Publicado: (2022)

Short-acting β(2)-agonist prescription patterns for asthma management in the SABINA III primary care cohort
por: Price, David, et al.
Publicado: (2022)

The use of electronic alerts in primary care computer systems to identify the excessive prescription of short-acting beta(2)-agonists for people with asthma: a systematic review
por: McKibben, Shauna, et al.
Publicado: (2018)

Healthcare resources, organisational support and practice in asthma in six public health clinics in Malaysia
por: Hussein, Norita, et al.
Publicado: (2023)

Factors Associated with Failure of Intermittent Nebulization with Short-Acting Beta-Agonists in Children with Severe Asthma Exacerbation
por: Kulalert, Prapasri, et al.
Publicado: (2020)

Improvement in symptom-related disruptions is associated with fewer days of short-acting beta-agonist use in asthma
por: Kaye, Leanne, et al.
Publicado: (2022)

Prediction of short-acting beta-agonist usage in patients with asthma using temporal-convolutional neural networks
por: Hirons, Nicholas, et al.
Publicado: (2023)

Over-prescription of short-acting β(2)-agonists and asthma management in the Gulf region: a multicountry observational study
por: Alzaabi, Ashraf, et al.
Publicado: (2022)

Over-prescription of short-acting β(2)-agonists for asthma in South Africa: Results from the SABINA III study
por: Smith, C, et al.
Publicado: (2022)

Quality of hypertension management in public primary care clinics in Malaysia: An update
por: Teh, Xin Rou, et al.
Publicado: (2020)

Improving the effectiveness of service delivery in the public healthcare sector: the case of ophthalmology services in Malaysia
por: Foo, Chee Yoong, et al.
Publicado: (2015)

Prevalence of overuse of short-acting beta-2 agonists (SABA) and associated factors among patients with asthma in Germany
por: Worth, Heinrich, et al.
Publicado: (2021)

Short-Acting Beta2-Agonist Use in Asthma in Korea: A 10-Year Population-Based Study
por: Lee, Hyun, et al.
Publicado: (2021)

The prevalence and outcome of short-acting β2-agonists overuse in asthma patients in Taiwan
por: Wang, Cheng-Yi, et al.
Publicado: (2021)

The use of electronic alerts in primary care computer systems to identify the over-prescription of short-acting beta(2)-agonists in people with asthma: a protocol for a systematic review
por: McKibben, Shauna, et al.
Publicado: (2017)

Comparison between primary care service delivery in Malaysia and other participating countries of the QUALICOPC project: a cross-sectional study
por: Lim, Ming Tsuey, et al.
Publicado: (2021)

Perceptions of childhood asthma and its control among Malays in Malaysia: a qualitative study
por: Sukri, Nursyuhada, et al.
Publicado: (2020)

Over-the-counter use of short-acting beta-2 agonists: a systematic review
por: Loh, Zhe Chi, et al.
Publicado: (2023)

Comparative performance of public and private primary care service delivery in Malaysia: An analysis of findings from QUALICOPC
por: Ong, Su Miin, et al.
Publicado: (2022)

Stakeholders’ views of supporting asthma management in schools with a school-based asthma programme for primary school children: a qualitative study in Malaysia
por: Ramdzan, Siti Nurkamilla, et al.
Publicado: (2022)

Translation and Validation of the Questionnaire on Acceptance to Telemedicine from the Technology Acceptance Model (TAM) for Use in Malaysia
por: Husin, Masliyana, et al.
Publicado: (2022)

Combination therapy of inhaled steroids and long-acting beta2-agonists in asthma–COPD overlap syndrome
por: Lee, Suh-Young, et al.
Publicado: (2016)

Reducing short-acting beta-agonist overprescribing in asthma: lessons from a quality-improvement prescribing project in East London
por: De Simoni, Anna, et al.
Publicado: (2022)

Loss of Asthma Control in Pediatric Patients after Discontinuation of Long-Acting Beta-Agonists
por: R. O'Hagan, Adrian, et al.
Publicado: (2012)

Add-on Therapy for Symptomatic Asthma despite Long-Acting Beta-Agonists/Inhaled Corticosteroid
por: Dreher, Michael, et al.
Publicado: (2018)

“Tossing a coin:” defining the excessive use of short-acting beta(2)-agonists in asthma—the views of general practitioners and asthma experts in primary and secondary care
por: McKibben, Shauna, et al.
Publicado: (2018)

A Cross-Sectional Study on Prescription Patterns of Short-Acting β(2)-Agonists in Patients with Asthma: Results from the SABINA III Colombia Cohort
por: Pedrozo-Pupo, John Carlos, et al.
Publicado: (2022)

Developing a Smartphone Application That Promotes Responsible Short-Acting Beta2-Agonist Use in People with Asthma: A Participatory Design
por: van den Berg, Liselot N., et al.
Publicado: (2022)

SABINA: An Overview of Short-Acting β(2)-Agonist Use in Asthma in European Countries
por: Janson, Christer, et al.
Publicado: (2020)

It is time to end our love affair with short-acting β(2)-agonists in asthma
por: Crooks, Michael G., et al.
Publicado: (2022)

Short-acting β(2)-agonists and exacerbations in children with asthma in England: SABINA Junior
por: Morgan, Ann, et al.
Publicado: (2023)

Zika virus infection in Malaysia: an epidemiological, clinical and virological analysis
por: Woon, Yuan Liang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_h29l9v99ludq8f6pij285r5tph